Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Regeneus Ltd. ( (AU:CMB) ) has shared an announcement.
Cambium Bio Limited, trading on the ASX under the symbol CMB, has issued 4,570,665 ordinary shares without the need for disclosure to investors, as permitted under the Corporations Act 2001. The company confirms compliance with relevant provisions of the Act and states that there is no excluded information requiring disclosure. This move is part of the company’s ongoing regulatory compliance and operational transparency.
More about Regeneus Ltd.
Average Trading Volume: 15,250
Technical Sentiment Signal: Sell
Current Market Cap: A$6.58M
See more data about CMB stock on TipRanks’ Stock Analysis page.